Clinical studies with chemokine receptor-5 (CCR5)-inhibitors.

Boesecke, Christoph; Pett, Sarah L

Boesecke, Christoph; Pett, Sarah L.

Affiliation

Boesecke C; Department of Internal Medicine I, University of Bonn, Bonn, Germany.

Curr Opin HIV AIDS ; 7(5): 456-62, 2012 Sep.

Article in En | MEDLINE | ID: mdl-22832708

Subject(s)

Antiviral Agents/therapeutic use; CCR5 Receptor Antagonists; HIV Infections/drug therapy; Antibodies, Monoclonal/adverse effects; Antibodies, Monoclonal/pharmacokinetics; Antibodies, Monoclonal/therapeutic use; Antiviral Agents/adverse effects; Antiviral Agents/pharmacokinetics; Coinfection/drug therapy; Cyclohexanes/adverse effects; Cyclohexanes/pharmacokinetics; Cyclohexanes/therapeutic use; HIV/genetics; HIV/physiology; HIV Antibodies/adverse effects; HIV Antibodies/therapeutic use; HIV Infections/complications; Hepatitis C, Chronic/drug therapy; Humans; Maraviroc; Molecular Diagnostic Techniques/methods; Triazoles/adverse effects; Triazoles/pharmacokinetics; Triazoles/therapeutic use; Viral Tropism; Virology/methods

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / HIV Infections / CCR5 Receptor Antagonists Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Curr Opin HIV AIDS Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2012 Document type: Article Affiliation country: Germany Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google